Stock listing
Medicus Pharma Ltd.
Selected listing: MDCX · NASDAQ · USD · US
Medicus Pharma Ltd. (NASDAQ:MDCX), Health Technology. Latest release Sep 29, 2026: Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA…
- Ticker
- NASDAQ:MDCX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Medicus Pharma Ltd.
Medicus Pharma Ltd. (ticker: MDCX) is a public company operating in the American market.
Latest news from Medicus Pharma Ltd.
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
September 29, 2026
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
September 21, 2026
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
September 10, 2026
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
September 8, 2026
Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026